RA
WST icon

RFG Advisory’s West Pharmaceutical WST Stock Holding History

RFG Advisory’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,587
Closed -$437K – 1115
2025
Q4 		$437K Sell
1,587
-646
-29% -$177K 0.01% 751
2025
Q3 		$586K Buy
2,233
+47
+2% +$11.4K 0.01% 622
2025
Q2 		$478K Buy
2,186
+288
+15% +$61.6K 0.01% 646
2025
Q1 		$425K Buy
1,898
+219
+13% +$60.4K 0.01% 612
2024
Q4 		$550K Buy
1,679
+15
+0.9% +$4.72K 0.02% 499
2024
Q3 		$500K Buy
1,664
+165
+11% +$50.5K 0.02% 518
2024
Q2 		$494K Buy
1,499
+34
+2% +$12K 0.02% 502
2024
Q1 		$580K Buy
1,465
+33
+2% +$12.2K 0.02% 476
2023
Q4 		$504K Sell
1,432
-29
-2% -$10.3K 0.02% 444
2023
Q3 		$548K Buy
1,461
+20
+1% +$7.73K 0.02% 391
2023
Q2 		$551K Buy
1,441
+259
+22% +$92.5K 0.02% 402
2023
Q1 		$410K Buy
1,182
+26
+2% +$7.6K 0.02% 451
2022
Q4 		$316K Buy
1,156
+86
+8% +$20.4K 0.02% 504
2022
Q3 		$240K Buy
1,070
+64
+6% +$19.5K 0.01% 547
2022
Q2 		$344K Sell
1,006
-122
-11% -$39.7K 0.02% 436
2022
Q1 		$463K Sell
1,128
-217
-16% -$85K 0.03% 341
2021
Q4 		$631K Sell
1,345
-27
-2% -$11.6K 0.04% 264
2021
Q3 		$583K Sell
1,372
-69
-5% -$29.1K 0.05% 251
2021
Q2 		$518K Sell
1,441
-294
-17% -$97.1K 0.05% 263
2021
Q1 		$489K Buy
1,735
+19
+1% +$5.44K 0.05% 256
2020
Q4 		$528K Sell
1,716
-5
-0.3% -$1.4K 0.07% 232
2020
Q3 		$473K Buy
1,721
+210
+14% +$55.6K 0.07% 239
2020
Q2 		$343K Buy
1,511
+176
+13% +$34.6K 0.05% 261
2020
Q1 		$203K Buy
+1,335
New +$205K 0.04% 323

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

RFG Advisory's WST Position: Q1 2026 in Review

RFG Advisory sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 1,587 shares — an estimated $437K sold.

RFG Advisory first reported a position in WST in Q1 2020 and held it in 24 quarters. The position peaked at $631K in Q4 2021. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • RFG Advisory reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • RFG Advisory sold 1,587 West Pharmaceutical shares in Q1 2026, an estimated $437K.
  • RFG Advisory first reported a position in West Pharmaceutical in Q1 2020 and held it in 24 quarters.
  • RFG Advisory's West Pharmaceutical position peaked at $631K in Q4 2021.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on RFG Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.